Thursday, July 29, 2021 1:21:07 AM
File Date Form Security Prev
Shares Current
Shares Change
(Percent) Ownership
(Percent) Change
(Percent)
2021-01-15 13G INTRACOASTAL CAPITAL, LLC 3,749,923 4.99
2021-01-15 13G CVI Investments, Inc. 3,800,000 5.30
2021-01-14 13G Empery Asset Management, LP 3,800,000 5.32
More recent filings..
2021-05-13 13F Renaissance Technologies Llc 1.53 3,304,140 570.48 6,972 1,389.74
2021-05-14 13F Vanguard Group Inc 1.53 3,180,565 513.88 6,711 1,264.02
2021-06-01 NP VTSMX - Vanguard Total Stock Market Index Fund Investor Shares [click for advisory] 2,080,920 4,391
2021-05-07 13F BlackRock Inc. 1.80 1,532,282 228,940.66 3,233 323,200.00
2021-06-01 NP VEXMX - Vanguard Extended Market Index Fund Investor Shares [click for advisory] 1,000,089 2,110
2021-05-12 13F Geode Capital Management, Llc 1.53 488,114 442.93 1,029 1,110.59
2021-05-17 13F Cvi Holdings, Llc 432,305 912
2021-07-22 NP FSMAX - Fidelity Extended Market Index Fund [click for advisory] 362,917 1,169
2021-05-19 13F Virtu Financial LLC 1.53 271,937 -1.22 574 119.08
2021-05-17 13F Sabby Management, Llc 242,237 511
2021-05-17 13F Morgan Stanley 1.06 197,733 732,244.44 418
2021-05-12 13F Northern Trust Corp 1.52 145,648 1,258.53 307 2,970.00
2021-05-18 13F Jane Street Group, Llc 94,810 200
2021-07-22 NP FSKAX - Fidelity Total Market Index Fund [click for advisory] 88,019 283
2021-07-19 13F Cutler Group LP 4.20 72,179 63.94 456 395.65
2021-05-13 13F Barclays Plc 1.52 65,694 455.69 139 1,163.64
2021-05-17 13F Goldman Sachs Group Inc 63,770 135
2021-06-01 NP VITNX - Vanguard Institutional Total Stock Market Index Fund Institutional Shares [click for advisory] 60,800 128
2021-07-22 NP FNCMX - Fidelity Nasdaq Composite Index Fund [click for advisory] 60,434 195
2021-07-22 NP FCFMX - Fidelity Series Total Market Index Fund [click for advisory] 58,337 188
2021-05-14 13F Sculptor Capital LP 53,500 113
2021-05-17 13F Capstone Investment Advisors, Llc 51,257 108
2021-05-17 13F Edmond De Rothschild Holding S.a. 50,000 106
2021-05-17 13F Susquehanna International Group, Llp 1.53 49,256 -54.16 104 1.96
2021-04-30 13F Creative Planning 48,666 103
2021-05-17 13F Two Sigma Advisers, Lp 1.52 48,400 348.15 102 920.00
2021-07-26 13F Spire Wealth Management 4.55 48,000 6.67 335 252.63
2021-05-13 13F Bank of New York Mellon Corp 35,927 76
2021-05-21 13F/A Citadel Advisors Llc 1.54 34,070 -22.12 72 71.43
2021-05-04 13F Commonwealth Equity Services, Llc 31,383 66
2021-05-06 13F Meitav Dash Investments Ltd 30,000 63
2021-05-17 13F Bienville Capital Management, LLC 28,379
https://fintel.io/so/us/atos
Recent ATOS News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 05/10/2024 01:04:04 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/10/2024 01:00:05 PM
- Atossa Therapeutics Announces Support of New Breast Cancer Screening Guidelines • GlobeNewswire Inc. • 05/07/2024 12:30:00 PM
- Atossa Therapeutics Announces Expanded Research Agreement with Weill Cornell Medicine to Further Evaluate Synergy Between Antibody Drug Conjugates (ADCs) and (Z)-Endoxifen • GlobeNewswire Inc. • 04/29/2024 12:30:00 PM
- Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer • GlobeNewswire Inc. • 04/15/2024 12:30:00 PM
- Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare Conference • GlobeNewswire Inc. • 04/11/2024 12:30:00 PM
- Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100% Disease Control Rate After 24-Weeks of Treatment with (Z)-Endoxifen • GlobeNewswire Inc. • 04/09/2024 03:59:00 PM
- Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 04/01/2024 08:00:00 PM
- Atossa Therapeutics Provides Five-Year (Z)-Endoxifen Treatment Update on FDA-Approved "Expanded Access" Program for a U.S. Breast Cancer Patient • GlobeNewswire Inc. • 03/19/2024 12:30:00 PM
- Atossa Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirements • GlobeNewswire Inc. • 03/18/2024 12:30:00 PM
- Atossa Therapeutics Appoints Breast Cancer Specialist Tessa Cigler, M.D., M.P.H. to its Board of Directors • GlobeNewswire Inc. • 03/12/2024 12:30:00 PM
- Atossa Therapeutics Announces First Patient Dosing of (Z)-Endoxifen in the Ongoing RECAST DCIS Study • GlobeNewswire Inc. • 02/22/2024 01:30:00 PM
- Atossa Therapeutics Announces Full Enrollment of (Z)-Endoxifen Arm of I-SPY 2 Clinical Trial • GlobeNewswire Inc. • 02/07/2024 01:30:00 PM
- Atossa Therapeutics Issues Letter to Shareholders • GlobeNewswire Inc. • 01/09/2024 01:30:00 PM
- Atossa Therapeutics Announces the Appointment of Arezoo Mirad, M.D., as Senior Medical Director • GlobeNewswire Inc. • 12/04/2023 01:30:00 PM
- Atossa Therapeutics Announces Full Enrollment of Phase 2 Karisma-Endoxifen Clinical Trial • GlobeNewswire Inc. • 11/20/2023 01:30:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/15/2023 09:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/15/2023 09:05:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 02:10:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 02:00:13 PM
- Atossa Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/13/2023 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 02:00:40 PM
- Atossa Therapeutics Appoints Financial Executive Jonathan Finn to its Board of Directors • GlobeNewswire Inc. • 11/09/2023 02:00:00 PM
- Quantum Leap Healthcare Collaborative Initiates Landmark Phase 2 RECAST DCIS Platform Trial to Evaluate Alternative DCIS Treatments with Atossa Therapeutics, Havah Therapeutics, and the Menarini Group • PR Newswire (US) • 10/30/2023 05:00:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM